Search

Your search keyword '"Bouvier, Nancy"' showing total 101 results

Search Constraints

Start Over You searched for: Author "Bouvier, Nancy" Remove constraint Author: "Bouvier, Nancy" Database Unpaywall Remove constraint Database: Unpaywall
101 results on '"Bouvier, Nancy"'

Search Results

1. Use of an application that extracts and consolidates adverse events and concomitant medication data from clinical systems to increase clinical trial data entry efficiency, trust, and satisfaction.

2. 45. Clonal hematopoiesis in childhood cancer survivors

3. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma

4. Clonal hematopoiesis in survivors of childhood cancer

5. Clonal evolution during metastatic spread in high-risk neuroblastoma

6. Data from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

7. Supplementary Table 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

8. Data from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

9. Supplementary Figure 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

10. Supplementary Table 2 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

11. Data from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

12. Supplementary Figure Legends from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

13. Supplementary Figure 2 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

14. Data from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

15. Supplementary Figure 3 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

16. Figure S1 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

17. Supplementary Figure Legends from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

18. Supplementary Figure 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

19. Supplementary Figure 2 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

20. Figure S2 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

21. Data from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

22. Supplementary Tables S1-S10 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

23. Supplementary Figure Legends from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

24. Figure S3 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

25. Figure S4 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

26. Figure S4 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

27. Supplementary Figure 3 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

28. Figure S2 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

29. Figure S1 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

30. Figure S3 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

31. Supplementary Figure 4 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

32. Supplementary Figure 4 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

33. Supplementary Figure Legends from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

34. Figure S1 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

35. Supplementary Table 2 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

36. Figure S2 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

37. Supplementary Tables S1-S10 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

38. Figure S2 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

39. Supplementary Table 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

40. Figure S1 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

41. Data from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

42. Supplemental Data (Figures and Tables) from DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma

43. Supplemental Data (Figures and Tables) from DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma

44. Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma

45. Abstract B022: Subclonal somatic copy number alterations emerge and dominate in relapsed/refractory osteosarcoma

46. Clonal evolution during metastatic spread in high-risk neuroblastoma

48. Abstract 704: Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine

49. Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma.

50. HGG-35. Radiation Induced High Grade Gliomas: A Single Center Experience

Catalog

Books, media, physical & digital resources